These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
378 related articles for article (PubMed ID: 32674598)
1. Bempedoic Acid: A New Drug for an Old Problem. Nguyen D; Du N; Sulaica EM; Wanat MA Ann Pharmacother; 2021 Feb; 55(2):246-251. PubMed ID: 32674598 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: A randomized, placebo-controlled study. Ballantyne CM; Banach M; Mancini GBJ; Lepor NE; Hanselman JC; Zhao X; Leiter LA Atherosclerosis; 2018 Oct; 277():195-203. PubMed ID: 29910030 [TBL] [Abstract][Full Text] [Related]
3. Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia. Banach M; Duell PB; Gotto AM; Laufs U; Leiter LA; Mancini GBJ; Ray KK; Flaim J; Ye Z; Catapano AL JAMA Cardiol; 2020 Oct; 5(10):1124-1135. PubMed ID: 32609313 [TBL] [Abstract][Full Text] [Related]
4. Bempedoic Acid: A New Tool in the Battle Against Hyperlipidemia. Powell J; Piszczatoski C Clin Ther; 2021 Feb; 43(2):410-420. PubMed ID: 33384162 [TBL] [Abstract][Full Text] [Related]
5. Evaluating pharmacokinetics of bempedoic acid in the treatment of hypercholesterolemia. Cicero AFG; Fogacci F; Cincione I Expert Opin Drug Metab Toxicol; 2021 Sep; 17(9):1031-1038. PubMed ID: 34197267 [No Abstract] [Full Text] [Related]
6. Bempedoic Acid for Heterozygous Familial Hypercholesterolemia: From Bench to Bedside. Agarwala A; Quispe R; Goldberg AC; Michos ED Drug Des Devel Ther; 2021; 15():1955-1963. PubMed ID: 34007155 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of bempedoic acid for prevention of cardiovascular events and diabetes: a systematic review and meta-analysis. Wang X; Zhang Y; Tan H; Wang P; Zha X; Chong W; Zhou L; Fang F Cardiovasc Diabetol; 2020 Aug; 19(1):128. PubMed ID: 32787939 [TBL] [Abstract][Full Text] [Related]
8. Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol. Ray KK; Bays HE; Catapano AL; Lalwani ND; Bloedon LT; Sterling LR; Robinson PL; Ballantyne CM; N Engl J Med; 2019 Mar; 380(11):1022-1032. PubMed ID: 30865796 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance. Laufs U; Banach M; Mancini GBJ; Gaudet D; Bloedon LT; Sterling LR; Kelly S; Stroes ESG J Am Heart Assoc; 2019 Apr; 8(7):e011662. PubMed ID: 30922146 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of bempedoic acid in patients with heterozygous familial hypercholesterolemia: analysis of pooled patient-level data from phase 3 clinical trials. Duell PB; Banach M; Catapano AL; Laufs U; Mancini GBJ; Ray KK; Broestl C; Zhang Y; Lei L; Goldberg AC J Clin Lipidol; 2024; 18(2):e153-e165. PubMed ID: 38341323 [TBL] [Abstract][Full Text] [Related]
11. Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy. Ballantyne CM; Laufs U; Ray KK; Leiter LA; Bays HE; Goldberg AC; Stroes ES; MacDougall D; Zhao X; Catapano AL Eur J Prev Cardiol; 2020 Apr; 27(6):593-603. PubMed ID: 31357887 [TBL] [Abstract][Full Text] [Related]
12. Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease: The CLEAR Wisdom Randomized Clinical Trial. Goldberg AC; Leiter LA; Stroes ESG; Baum SJ; Hanselman JC; Bloedon LT; Lalwani ND; Patel PM; Zhao X; Duell PB JAMA; 2019 Nov; 322(18):1780-1788. PubMed ID: 31714986 [TBL] [Abstract][Full Text] [Related]
13. Bempedoic acid, an inhibitor of ATP citrate lyase for the treatment of hypercholesterolemia: early indications and potential. Brandts J; Ray KK Expert Opin Investig Drugs; 2020 Aug; 29(8):763-770. PubMed ID: 32564642 [TBL] [Abstract][Full Text] [Related]
14. Role of Bempedoic Acid in Dyslipidemia Management. Kelly MS; Sulaica EM; Beavers CJ J Cardiovasc Pharmacol; 2020 Oct; 76(4):376-388. PubMed ID: 32732494 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of bempedoic acid for the treatment of hypercholesterolemia: A systematic review and meta-analysis. Cicero AFG; Fogacci F; Hernandez AV; Banach M; PLoS Med; 2020 Jul; 17(7):e1003121. PubMed ID: 32673317 [TBL] [Abstract][Full Text] [Related]
16. Bempedoic Acid: a cholesterol lowering agent with a novel mechanism of action. Nguyen H; Akamnonu I; Yang T Expert Rev Clin Pharmacol; 2021 May; 14(5):545-551. PubMed ID: 33691561 [TBL] [Abstract][Full Text] [Related]
17. Bempedoic acid safety analysis: Pooled data from four phase 3 clinical trials. Bays HE; Banach M; Catapano AL; Duell PB; Gotto AM; Laufs U; Leiter LA; Mancini GBJ; Ray KK; Bloedon LT; Sasiela WJ; Ye Z; Ballantyne CM J Clin Lipidol; 2020; 14(5):649-659.e6. PubMed ID: 32980290 [TBL] [Abstract][Full Text] [Related]
18. Greater than expected reduction in low-density lipoprotein-cholesterol (LDL-C) with bempedoic acid in a patient with heterozygous familial hypercholesterolemia (HeFH). Agha AM; Jones PH; Ballantyne CM; Virani SS; Nambi V J Clin Lipidol; 2021; 15(5):649-652. PubMed ID: 34393074 [TBL] [Abstract][Full Text] [Related]
19. Bempedoic Acid (Nexletol) for the Treatment of Hyperlipidemia and Familial Hypercholesterolemia. Lawrence E; Johns T Am Fam Physician; 2021 Mar; 103(6):377-378. PubMed ID: 33719370 [No Abstract] [Full Text] [Related]
20. A Review of the Efficacy and Tolerability of Bempedoic Acid in the Treatment of Hypercholesterolemia. Niman S; Rana K; Reid J; Sheikh-Ali M; Lewis T; Choksi RR; Goldfaden RF Am J Cardiovasc Drugs; 2020 Dec; 20(6):535-548. PubMed ID: 32166726 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]